ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
LCN2-Driven Fibroblast Ferroptosis-Associated Injury Promotes Keratinocyte Proliferation via Lipid Peroxidation Signaling in Psoriasis.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Psoriasis is a chronic inflammatory skin disorder in which biologics targeting immune pathways have markedly improved clinical outcomes. Nevertheless, persistent oxidative stress and stromal abnormalities in lesional skin indicate that pathogenic mechanisms beyond canonical immune circuits remain active. Here, we integrated single-cell RNA sequencing, an imiquimod (IMQ)-induced psoriasiform murine model, LC-MS/MS-based metabolomic profiling of fibroblast-conditioned medium, and complementary in vitro studies to define ferroptosis-related alterations in dermal fibroblasts under psoriasis-like inflammatory conditions. Single-cell analysis revealed a marked expansion of an inflammatory fibroblast subset (iFb1) in psoriasiform lesions, together with enrichment of ferroptosis-related pathways. In vivo and in vitro analyses further showed that inflammatory stimulation induced ferroptosis-related injury in dermal fibroblasts, as evidenced by increased lipid peroxidation, impaired antioxidant defenses, and characteristic ultrastructural alterations. Metabolomic profiling of conditioned medium further indicated secretory remodeling characterized by enrichment of lipid mediators and redox-associated metabolites. Lipocalin-2 (LCN2) was significantly upregulated in psoriasis-associated fibroblasts and exacerbated lipid peroxidation and ferroptosis-related injury. Conditioned medium from inflammation-stimulated fibroblasts enhanced keratinocyte proliferation, whereas inhibition of fibroblast ferroptosis or LCN2 knockdown attenuated this effect. Further experiments suggested that 4-hydroxy-2-nonenal (4-HNE) may act as a potential mediator of fibroblast-keratinocyte crosstalk. Topical administration of carnosine, a potent 4-HNE scavenger, alleviated IMQ-induced psoriasiform skin lesions in vivo. Together, these findings support an LCN2-driven fibroblast-keratinocyte crosstalk axis linked to ferroptosis-related injury in psoriasis and highlight stromal lipid peroxidation as a potential therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.